Cardlytics, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Cardlytics, Inc. on July 7, 2025. The filing reports the entry into a material definitive agreement on the same date.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on the terms of a contractual amendment.
Material Changes
On July 7, 2025, the Company entered into a Fourth Amendment to Schedule #1 of its Master Agreement with JPMorgan Chase Bank, National Association. Key changes include:
- Term Extension: The agreement term is extended until November 18, 2028.
- Supplier Billings Share: The share of billings retained by the Company will be reduced beginning January 1, 2026.
- Relative Position: Despite the reduction, the new Supplier Billings Share remains higher than the level established prior to the Third Amendment.
- Other Amendments: Provisions regarding Incentive Bonus, Quality Credits, and certain other matters were amended.
Guidance, Outlook, and Risks
The filing does not contain updated financial guidance, management commentary on future performance, or a discussion of general risks. The full text of the Fourth Amendment, which contains the complete terms, is scheduled to be filed as an exhibit to the Company's Form 10-Q for the quarter ended June 30, 2025.
Investor Verification Checklist
- Review the full text of the Fourth Amendment in the upcoming Form 10-Q for the quarter ended June 30, 2025.
- Verify the specific percentage reduction in the Supplier Billings Share effective January 1, 2026.
- Assess the impact of the reduced billings share on future gross margins and profitability.
- Confirm the details of the amended Incentive Bonus and Quality Credit provisions.